Gilles Salles, MD, PhD, from South Lyon Hospital Complex, Lyon, France discusses the management of patients with follicular lymphoma in the first-line and relapsed setting. Prof Salles outlines the different treatment approaches for patients with limited stage and extended stage disease. For example, patients with limited stage disease may receive radiation therapy and for patients with a high-tumor burden, the standard of care has been chemotherapy plus an anti-CD20 such as rituximab. Prof Salles further discusses the option of a chemotherapy-free approach and the various options in the relapsed setting.
Recorded at the 2016 Annual Meeting of the British Society of Haematology (BSH) and International Society of Hematology (ISH), held in Glasgow, Scotland.